<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Canatu Plc — News on 6ix</title>
    <link>https://6ix.com/company/canatu-plc</link>
    <description>Latest news and press releases for Canatu Plc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 24 Oct 2025 13:04:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/canatu-plc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d52263beedb30cb6f67f5d.webp</url>
      <title>Canatu Plc</title>
      <link>https://6ix.com/company/canatu-plc</link>
    </image>
    <item>
      <title>Canatu grants license for commercial production of CNT pellicle membranes using CNT100 SEMI reactor</title>
      <link>https://6ix.com/company/canatu-plc/news/canatu-grants-license-for-commercial-production-of-cnt-pellicle-membranes-using-cnt100-semi-reactor-1</link>
      <guid isPermaLink="true">https://6ix.com/company/canatu-plc/news/canatu-grants-license-for-commercial-production-of-cnt-pellicle-membranes-using-cnt100-semi-reactor-1</guid>
      <pubDate>Fri, 24 Oct 2025 13:04:00 GMT</pubDate>
      <description>Canatu CNT pellicle membrane Canatu CNT SEMI 100 reactors are used for CNT pellicle membrane production VANTAA, Finland, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Canatu has granted a commercial production license for the first CNT100 SEMI reactor to Korean semiconductor company FINE SEMITECH CORPORATION (hereinafter “FST”). The license authorizes FST as the licensee to mass-produce CNT pellicle membranes using the CNT100 SEMI reactor, which will be operated by FST. FST will pay Canatu a one-time licens</description>
    </item>
    <item>
      <title>Canatu receives customer approval for its CNT100 SEMI reactor and post-processing equipment, enabling mass production of advanced EUV pellicles</title>
      <link>https://6ix.com/company/canatu-plc/news/canatu-receives-customer-approval-for-its-cnt100-semi-reactor-and-post-processing-equipment-enabling-mass-production-of-advanced-euv-pellicles-1</link>
      <guid isPermaLink="true">https://6ix.com/company/canatu-plc/news/canatu-receives-customer-approval-for-its-cnt100-semi-reactor-and-post-processing-equipment-enabling-mass-production-of-advanced-euv-pellicles-1</guid>
      <pubDate>Fri, 11 Jul 2025 10:42:00 GMT</pubDate>
      <description>Vantaa, Finland, July 11, 2025 (GLOBE NEWSWIRE) -- Canatu Plc (CANATU, Nasdaq First North, Finland) has received Site Acceptance Test (SAT) approval for its first CNT100 SEMI reactor and for the related post-processing peripherals, shipped to a semiconductor customer in September 2024. The equipment successfully passed the extensive tests conducted on-site at the customer’s premises and met the stringent technical requirements and specifications defined in the acceptance criteria. This confirms</description>
    </item>
  </channel>
</rss>